Operationalizing Bioethics in Pharma

Our team of bioethicists and analysts are dedicated to advancing patient and global health, by ensuring pharma innovates responsibly and puts patients first.

Our Mission

Our mission is to help transform the way we understand, engage, and operationalize bioethics in the healthcare innovation sector to improve its trustworthiness and patient-centricity and advance health.


We are one for everyone—one organization to develop, monitor and disseminate industry benchmarks, and better the efforts and wellbeing of all healthcare stakeholders. We are one meeting place for physicians, patients, regulators, and pharmaceutical companies to come to the table to discuss what works, what needs improvement, and most importantly, where we can go together.

Our History

Bioethics International (BEI) was co-founded in 2005, by Dr. Jennifer E. Miller to advance ethics and patient-centricity in medicine. BEI was incorporated as a 501c3 in the State of New York in 2006 and awarded public charity status by the IRS in 2007. We publicly launched the Good Pharma Scorecard (GPS) at a multi-stakeholder meeting in NYC in 2009. Our first set of GPS rankings, were released in partnership with Harvard University’s Edmond J. Safra Center for Ethics, in 2015.  Today, the charity has grown to include a great team of researchers, advisors, and directors and a vast network of representatives from foundations, industry, patient groups, government, academia, and socially responsible investors.